financetom
Business
financetom
/
Business
/
RBC on BMO's Q4 -- Says Past Credit Concern
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC on BMO's Q4 -- Says Past Credit Concern
Dec 6, 2024 11:00 AM

01:44 PM EST, 12/06/2024 (MT Newswires) -- BMO identified larger loans in the 2021 vintage that caused credit issues in 2024 and it expects fourth-quarter impaired PCL ratio to be the peak, moderating to historical averages by the end of 2025/early 2026, writes RBC.

Analyst Darko Mihelic sees a rapid increase in EPS into 2026 (assuming buybacks).

Increasing price target to $133 (from $106). Maintaining Sector Perform.

Price: 145.80, Change: +6.07, Percent Change: +4.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Assisted living firm Sonida's Q2 resident revenue up 29.7%
Assisted living firm Sonida's Q2 resident revenue up 29.7%
Aug 11, 2025
Overview * Sonida Q2 2025 resident revenue rises 29.7% yr/yr due to acquisitions * Net loss narrows to $1.6 mln from $9.8 mln in Q2 2024 * Adjusted EBITDA increases 23.7% yr/yr, reflecting operational improvements Outlook * Sonida expects stronger NOI and margin growth in upcoming quarters * Company anticipates capitalizing on long-term growth in senior housing * Sonida sees...
Biogen, Stoke Therapeutics Dose First Patient in Phase 3 Trial of Zorevunersen for Dravet Syndrome
Biogen, Stoke Therapeutics Dose First Patient in Phase 3 Trial of Zorevunersen for Dravet Syndrome
Aug 11, 2025
08:24 AM EDT, 08/11/2025 (MT Newswires) -- Biogen (BIIB) and Stoke Therapeutics ( STOK ) said Monday they have dosed a first participant in a phase 3 trial evaluating zorevunersen, an investigational antisense oligonucleotide, for the treatment of Dravet syndrome. The phase 3 trial will evaluate the safety and efficacy of zorevunersen compared to sham over a 52-week period, Biogen...
Paramount secures UFC rights in the US in $7.7 billion deal
Paramount secures UFC rights in the US in $7.7 billion deal
Aug 11, 2025
(Reuters) -Skydance-owned Paramount will become the exclusive U.S. home of Ultimate Fighting Championship under a seven-year rights deal with TKO Group Holdings, starting in 2026, that is valued at around $7.7 billion, the companies said on Monday. Paramount shares were up 4.2% in premarket trading. The company will carry the UFC's full U.S. slate of 13 numbered events and 30...
Copyright 2023-2026 - www.financetom.com All Rights Reserved